Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIDES: TCM for Ischemic Stroke with Diabetes
NCT07121088Phase 4Not yet recruiting
- Sponsor
- Guangzhou University of Chinese Medicine
- Start
- Aug 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
Phase 4, open-label trial of chuanzhitongluojiaonang in ischemic stroke (2 arms), sponsored by Guangzhou University of Chinese Medicine. Primary endpoint: Modified Rankin Scale Score 0-2 at 90 days. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
chuanzhitongluojiaonang
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07121088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07121088.